BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36293443)

  • 1. Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-Containing Five-Membered Heterocyclic Hybrids Bearing Sulfonamide Moiety.
    Castaño LF; Quiroga J; Abonia R; Insuasty D; Vidal OM; Seña R; Rubio V; Puerto G; Nogueras M; Cobo J; Guzman J; Insuasty A; Insuasty B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
    Castaño LF; Cuartas V; Bernal A; Insuasty A; Guzman J; Vidal O; Rubio V; Puerto G; Lukáč P; Vimberg V; Balíková-Novtoná G; Vannucci L; Janata J; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
    Eur J Med Chem; 2019 Aug; 176():50-60. PubMed ID: 31096118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives.
    Ngameni B; Cedric K; Mbaveng AT; Erdoğan M; Simo I; Kuete V; Daştan A
    Bioorg Med Chem Lett; 2021 Mar; 35():127827. PubMed ID: 33508467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.
    de Oliveira NS; de Souza LG; de Almeida VM; Barreto ARR; Carvalho-Gondim F; Schaeffer E; Santos-Filho OA; Rossi-Bergmann B; da Silva AJM
    Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300440. PubMed ID: 38048546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.
    Kasetti AB; Singhvi I; Nagasuri R; Bhandare RR; Shaik AB
    Molecules; 2021 May; 26(10):. PubMed ID: 34064806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient access to domain-integrated estradiol-flavone hybrids via the corresponding chalcones and their in vitro anticancer potential.
    Molnár B; Gopisetty MK; Nagy FI; Adamecz DI; Kása Z; Kiricsi M; Frank É
    Steroids; 2022 Nov; 187():109099. PubMed ID: 35970223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazopyridine chalcones as potent anticancer agents: Synthesis, single-crystal X-ray, docking, DFT and SAR studies.
    Soumyashree DK; Reddy DS; Nagarajaiah H; Naik L; Savanur HM; Shilpa CD; Sunitha Kumari M; Shanavaz H; Padmashali B
    Arch Pharm (Weinheim); 2023 Jul; 356(7):e2300106. PubMed ID: 37208792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
    Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
    Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects.
    Mohamed HS; Abdelgawad MA; Hegab M; Hamza ZS; Nagdy AM; Ahmed SA; Ahmed OM; Ghoneim MM
    Curr Org Synth; 2023; 20(3):339-350. PubMed ID: 36214306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
    Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Antiproliferative Activity of Novel Dehydroabietic Acid-Chalcone Hybrids.
    Grigoropoulou S; Manou D; Antoniou AI; Tsirogianni A; Siciliano C; Theocharis AD; Athanassopoulos CM
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
    Gibson MZ; Nguyen MA; Zingales SK
    Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Activity of Natural and Synthetic Chalcones.
    Constantinescu T; Lungu CN
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Bioactivity of Reduced Chalcones Containing Sulfonamide Side Chains.
    Noreljaleel AEM; Wilhelm A; Bonnet SL; van der Westhuizen JH
    J Nat Prod; 2018 Jan; 81(1):41-48. PubMed ID: 29309141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
    Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
    Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
    Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
    Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity of novel 3-(furan-2-yl)pyrazolyl and 3-(thiophen-2-yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies.
    Helmy MT; Sroor FM; Mahrous KF; Mahmoud K; Hassaneen HM; Saleh FM; Abdelhamid IA; Mohamed Teleb MA
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100381. PubMed ID: 34939695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and molecular docking study of novel quinoline-based bis-chalcones as potential antitumor agents.
    Insuasty D; García S; Abonia R; Insuasty B; Quiroga J; Nogueras M; Cobo J; Borosky GL; Laali KK
    Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100094. PubMed ID: 34050547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of selenophene-based chalcone analogs and assessment of their biological activity as anticancer agents.
    Chen YC; Li CW; Chen JJ; Shih TL
    Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200486. PubMed ID: 36587972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.